# OnCo record epigenetic-drugs (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/epigenetic-drugs/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "epigenetic-drugs" ;
  schema:name "Epigenetic drugs (HDAC, DNMT, EZH2, IDH, menin, BET)"@en ;
  schema:description "Drugs that change how genes are switched on and off without changing the DNA itself."@en ;
  schema:url <https://onco.cc/technologies/epigenetic-drugs/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Epigenetic_therapy> ;
  owl:sameAs <http://www.wikidata.org/entity/Q18353741> ;
  schema:citation <https://en.wikipedia.org/wiki/Epigenetic_therapy> ;
  onco:status "approved" ;
  onco:related <https://onco.cc/technologies/idh-inhibitors/>, <https://onco.cc/technologies/kat6-inhibitors/>, <https://onco.cc/technologies/lsd1-inhibitors/> ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:sections <https://onco.cc/fronts/epigenetics/> ;
  onco:targets <https://onco.cc/targets/idh/>, <https://onco.cc/targets/menin/>, <https://onco.cc/targets/ezh2/> ;
  onco:companies <https://onco.cc/companies/morphosys/>, <https://onco.cc/companies/amphista-therapeutics/>, <https://onco.cc/companies/foghorn-therapeutics/>, <https://onco.cc/companies/oric-pharmaceuticals/>, <https://onco.cc/companies/proxygen/>, <https://onco.cc/companies/treeline-biosciences/> .
